About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,217 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,217 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4521-4540 of 5,217 trials

CompletedGP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive GliomaVaccines made from a person's tumor cells, such as gp96 heat shock protein-peptide complex, may help the body build an effective immune response to kill tumor cells.NCT00293423·San Francisco, California and 2 others TerminatedAdvanced MR Imaging in Patients With Painful, Degenerative Disc Disease: A Pilot StudyIn this study, we will use advanced and newly available MR imaging techniques at 3 Tesla (including in situ axial loading and quantitative T1rho, T2, and diffusion measurements)…NCT00706459·San Francisco, California

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

CompletedCommunity Intervention Trial for Youth (CITY) StudyThe purpose of this study is to test whether a multi-component, community-level, HIV-prevention intervention is more effective than existing HIV prevention activities in reducing…NCT00164580·Birmingham, Alabama and 7 others

CompletedGM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerGM-CSF may protect normal cells from the side effects, such as mucositis, of radiation therapy and may help damaged tissue heal faster after radiation therapy.NCT00293462·San Francisco, California

RecruitingReducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent SystemThe REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure.NCT06360380·La Jolla, California and 9 others

Not yet recruitingN-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial CancerThis phase Ib trial will investigate the effect of N-803 in combination with pembrolizumab and enfortumab vedotin in treating participants with urothelial cancer that has spread…NCT07217496·San Francisco, California

CompletedS9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003127·Mobile, Alabama and 93 others

Active not recruitingA Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic TherapyThis study will be conducted to compare Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic…NCT06821542·Graz and 129 others

CompletedFREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)This study was an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who were currently receiving approved therapy for their PAH…NCT00325442·Birmingham, Alabama and 71 others

Active not recruitingBIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)Primary Objectives: * Cohort A: To evaluate the efficacy of BIVV020 in prevention of AMR * Cohort B: To evaluate the efficacy of BIVV020 in treatment of active AMR Secondary…NCT05156710·Los Angeles, California and 26 others

Active not recruitingA Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer.NCT03504397·Phoenix, Arizona and 219 others

CompletedA Study of LY2875358 in Participants With Advanced CancerThe objective of this study is to determine a recommended Phase 2 dose range of LY2875358 that may be safely administered to participants with advanced cancer.NCT01287546·La Jolla, California and 9 others

CompletedThe Healthy Heart StudyThe long-term goal of this research is to improve patient-centered outcomes in patients with coronary heart disease (CHD), the leading cause of death in the world.NCT02105246·San Francisco, California

TerminatedCombination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to kill tumor cells or stop them from growing.NCT01189227·Antioch, California and 282 others

TerminatedSTOP-T1D Low-Dose (ATG)A multi-center, placebo-controlled, double blind, 2:1 randomized control clinical trial testing low-dose ATG vs. placebo in subjects with a 2 year 50% risk of progression to stage…NCT04291703·Orange, California and 21 others

Active not recruitingParenting Stress mHealthParenting stress is a well-documented barrier to youth engagement in community-based substance use treatment.NCT05032742·San Francisco, California

CompletedStudy of NXN 188 for the Treatment of Migraine With AuraNXN-188 Dihydrochloride is being developed as an immediate release oral product for the treatment of acute migraine.NCT00920686·Newport Beach, California and 15 others

CompletedEfficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)AC220 will be administered as a once daily oral solution given continuously as 28-day treatment cycles, without any rest periods, until disease progression, relapse, intolerance…NCT00989261·San Francisco, California and 84 others

CompletedSafety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational AgeThe purpose of this study is to investigate the safety, efficacy and pharmacokinetics (PK) of dexmedetomidine (DEX) at 3 different dose levels in infants, ages ≥28 weeks to ≤44…NCT01159262·Little Rock, Arkansas and 17 others

RecruitingA Multi Center Study Testing a New Implant for Adults With Severe EmphysemaA study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.NCT07119229·San Francisco, California and 2 others

PreviousPage 227 of 261Next

Diabetes

in San Francisco

Heart Diseasein San Francisco